Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now
What is the process for starting Accutane
Mol Immunol 132:227235 Zhang Z, Chen W-Q, Zhang S-Q, Bai J-X, Lau C-L, Sze SC-W, Yung KK-L, Ko JK-S (2022) The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
It is important to highlight that the adoption of new and more appropriate terminology would require universal acceptance by clinicians, carers and patients who would have lived with the name PA for most of their lives
Fux M, Benjamin J, Belmaker RH